Alex Blyth's Interview about how LIfT came to be, and why we need to move on from mouse models
The Business of Biotech interviews serial inventor and entrepreneur Alex Blyth who had long held interests in health and science, but...
Welcome to LIfT BioSciences
LIfT BioSciences is developing a breakthrough allogeneic innate cell therapy platform that produces different types of Immunomodulatory Alpha Neutrophils (IMANs). LIfT's focus is on producing an exceptional type of anti-cancer alpha neutrophil with enhanced cytotoxic and immunomodulatory properties.
Our mission is to develop affordable curative therapies for solid tumours with high unmet medical need.
